Keen Vision Acquisition Corporation Warrant
KVACW
NASDAQ Global Market0.02
USD
+0.00
- -
Keen Vision Acquisition Corporation Warrant
KVACW
(NASDAQ Global Market)
Recent
price
0.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Keen Vision Acquisition Corporation Keen Vision Acquisition Corporation Warrant (KVACW) Keen Vision Acquisition Corporation Warrant provides holders the right to purchase ordinary shares of Keen Vision Acquisition Corporation , a blank check company incorporated in 2021 in the British Virgin Islands and headquartered in Summit, New Jersey, whose sole purpose involves pursuing mergers, share exchanges, asset acquisitions, share purchases, recapitalizations, reorganizations, or other business combinations, primarily targeting opportunities in biotechnology, consumer goods, and agriculture sectors with enterprise values up to $1 billion and emphasis on sustainability and ESG factors. The warrants, exercisable at a specified price and expiring on March 15, 2028, represent tradable securities linked to the SPAC's units listed on Nasdaq since its July 2023 IPO at $10 per unit via EF Hutton and Brookline Capital Markets. In September 2024, Keen Vision Acquisition Corporation announced a definitive reverse merger agreement with Medera Inc., a gene therapy biotechnology firm, at an enterprise value of approximately $620 million, including $22.6 million from Medera stakeholders and $149.5 million in committed capital, expected to close in Q4 2024 subject to liquidity and approvals, alongside recent financing such as a $0.2 million funding from sponsor KVC Sponsor LLC in March 2025 and a $144,670 promissory note issuance in July 2025.